Clariant AG
CLZNY
$12.08
-$0.28-2.27%
Weiss Ratings | CLZNY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Weak | |||
Risk Index | Weak | |||
Risk Grade | D | |||
Reward Grade | D+ | |||
Rating Factors | CLZNY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | -- | |||
Growth Index | Weak | |||
Efficiency Index | Fair | |||
Solvency Index | Good | |||
Total Return Index | Weak | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | CLZNY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 0.35 | |||
Price History | CLZNY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | -6.21% | |||
30-Day Total Return | 4.14% | |||
60-Day Total Return | -0.25% | |||
90-Day Total Return | -16.05% | |||
Year to Date Total Return | 3.69% | |||
1-Year Total Return | -6.98% | |||
2-Year Total Return | -24.84% | |||
3-Year Total Return | -23.97% | |||
5-Year Total Return | -58.61% | |||
52-Week High % Change | -29.25% | |||
52-Week Low % Change | 15.41% | |||
Price | CLZNY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $17.47 | |||
52-Week Low Price | $10.71 | |||
52-Week Low Price (Date) | Jan 14, 2025 | |||
52-Week High Price (Date) | Jul 18, 2024 | |||
Valuation | CLZNY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 4.00B | |||
Enterprise Value | 5.88B | |||
Price/Earnings (TTM) | 14.80 | |||
Earnings Per Share (TTM) | 0.84 | |||
Earnings Per Share Growth | -40.48% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | 0.87 | |||
Price/Book (Q) | 1.57 | |||
Enterprise Value/Revenue (TTM) | 1.25 | |||
Price | $12.08 | |||
Enterprise Value/EBITDA (TTM) | 9.21 | |||
Enterprise Value/EBIT | 14.34 | |||
Market Cap Category | Mid Cap | |||
Dividends and Shares | CLZNY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 330.33M | |||
Dividend Yield | 3.40% | |||
Div. Per Share (Most Recent) | $0.42 | |||
Dividend Per Share (TTM) | $0.42 | |||
Payout Ratio (TTM) | 56.57% | |||
Dividend Per Share (Most Recent) | $0.42 | |||
Company Info | CLZNY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | -- | |||
Address | -- | |||
Website | www.clariant.com | |||
Country | Switzerland | |||
Year Founded | 1886 | |||
Profitability | CLZNY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | 8.68% | |||
Profit Margin | 5.85% | |||
Management Effectiveness | CLZNY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | 3.86% | |||
Return on Equity | 11.85% | |||
Income Statement | CLZNY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 4.72B | |||
Total Revenue (TTM) | 4.72B | |||
Revenue Per Share | $14.28 | |||
Gross Profit (TTM) | 1.39B | |||
EBITDA (TTM) | 638.04M | |||
EBIT (TTM) | 409.60M | |||
Net Income (TTM) | 276.42M | |||
Net Income Avl. to Common (TTM) | 276.42M | |||
Total Revenue Growth (Q YOY) | -- | |||
Earnings Growth (Q YOY) | -- | |||
EPS Diluted (TTM) | 0.84 | |||
EPS Diluted Growth (Q YOY) | -58.11% | |||
Balance Sheet | CLZNY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 435.90M | |||
Cash Per Share (Q) | $1.32 | |||
Total Current Assets (Q) | 2.35B | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 2.77B | |||
Current Ratio (Q) | 1.467 | |||
Book Value Per Share (Q) | $7.85 | |||
Total Assets (Q) | 6.91B | |||
Total Current Liabilities (Q) | 1.60B | |||
Total Debt (Q) | 2.08B | |||
Total Liabilities (Q) | 4.14B | |||
Total Common Equity (Q) | 2.58B | |||
Cash Flow | CLZNY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -906.13M | |||
Cash from Financing (TTM) | 305.77M | |||
Net Change in Cash (TTM) | -112.05M | |||
Levered Free Cash Flow (TTM) | 111.57M | |||
Cash from Operations (TTM) | 477.09M | |||